Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amarin's Omega-3 Fair Trade Complaint Reaches Regulatory Dead End

Oct 31 2017

• By Malcolm Spicer

US International Trade Commission ITC in Washington DC

Related Content

FDA Finds Ingredient's IND Past After Signing Off For Supplement Use

Sep 07 2016

FDA Dismisses List Of “Grandfathered” Ingredients In Pyridoxamine Decision

Feb 02 2009

Off-Label Unleashed? Amarin Win Suggests Firms Still Need Strong Data To Skirt FDA

Aug 07 2015

Legal Briefs: Courts On Exclusivity; Namenda ‘Hard Switch’ Deemed Coercive; Acorda Fights Bass Patent Petition

Jun 01 2015

FDA Plants Oversight Flag On Amarin Trade Claim Against Omega-3 Ingredients

Oct 11 2017

Omega-3 Ingredients Fair Trade Complaint? Not FDA's Bailiwick, Amarin Says

Oct 19 2017

Ovos' Former IND Homotaurine Strikes Out As Dietary Ingredient

Feb 28 2011

Related Companies

Amarin Corp plc

BioStratum, Inc.

Additional Topics

Ireland Europe United States Dietary Supplements Ingredients FDA Regulation Trade Policy Consumer

More from Ingredients & Safety

More from HBW Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window